Details for New Drug Application (NDA): 215848
✉ Email this page to a colleague
NDA 215848 describes FLUPHENAZINE HYDROCHLORIDE, which is a drug marketed by Ani Pharms, Pharm Assoc, Fresenius Kabi Usa, Ajanta Pharma Ltd, Alembic, Amneal, Apotex, Aurobindo Pharma Ltd, Breckenridge, Dr Reddys, Glenmark Pharms Ltd, Hetero Labs Ltd Iii, Lannett Co Inc, MSN, Novitium Pharma, Prasco, Rising, Sandoz, Taro, Torrent, Twi Pharms, Upsher Smith Labs, Watson Labs, Zameer Pharms, and Zydus Lifesciences, and is included in thirty NDAs. It is available from twenty-nine suppliers. Additional details are available on the FLUPHENAZINE HYDROCHLORIDE profile page.
The generic ingredient in FLUPHENAZINE HYDROCHLORIDE is fluphenazine hydrochloride. There are nineteen drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the fluphenazine hydrochloride profile page.
The generic ingredient in FLUPHENAZINE HYDROCHLORIDE is fluphenazine hydrochloride. There are nineteen drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the fluphenazine hydrochloride profile page.
Summary for 215848
| Tradename: | FLUPHENAZINE HYDROCHLORIDE |
| Applicant: | Twi Pharms |
| Ingredient: | fluphenazine hydrochloride |
| Patents: | 0 |
Suppliers and Packaging for NDA: 215848
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| FLUPHENAZINE HYDROCHLORIDE | fluphenazine hydrochloride | TABLET;ORAL | 215848 | ANDA | Upsher-Smith Laboratories, LLC | 24979-136 | 24979-136-01 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (24979-136-01) |
| FLUPHENAZINE HYDROCHLORIDE | fluphenazine hydrochloride | TABLET;ORAL | 215848 | ANDA | Upsher-Smith Laboratories, LLC | 24979-137 | 24979-137-01 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (24979-137-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 2.5MG | ||||
| Approval Date: | Apr 1, 2022 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Apr 1, 2022 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Apr 1, 2022 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
